Myeloproliferative Neoplasms: Critical Concepts and Management by Tiziano BarbuiMyeloproliferative Neoplasms: Critical Concepts and Management by Tiziano Barbui

Myeloproliferative Neoplasms: Critical Concepts and Management

EditorTiziano Barbui, Ayalew Tefferi

Hardcover | February 3, 2012

Pricing and Purchase Info

$286.33 online 
$297.95 list price
Earn 1432 plum® points

In stock online

Ships free on orders over $25

Not available in stores


This book focuses on three of the main categories of myeloproliferative neoplasm: polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Relevant laboratory and clinical advances are comprehensively covered, and great emphasis is placed on the practical issues that challenge physicians in their daily practice. The main topics considered thus include contemporary diagnostic  approaches, the value and limitations of mutation screening for diagnostic and  prognostic purposes, risk stratification in terms of both survival and other  disease complications such as leukemic transformation and thrombosis, and  modern therapeutic strategies, including conventional drugs, allogeneic stem cell  transplantation, and experimental drugs still under study. The reader will find Critical Concepts and Management Recommendations in Myeloproliferative Neoplasms to be an invaluable and up-to-date source of information from leading authorities in the field.
The discovery of the JAK2 V617F mutation in the majority of patients with bcr/abl-negative myeloproliferative neoplasms has stimulated a number of questions regarding the diagnosis, prognosis, and treatment of polycythemia vera, essential thrombocythemia, and primary myelofibrosis. This book provides evidence-based reviews and expert c...
Title:Myeloproliferative Neoplasms: Critical Concepts and ManagementFormat:HardcoverDimensions:248 pagesPublished:February 3, 2012Publisher:Springer Berlin HeidelbergLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3642249884

ISBN - 13:9783642249884

Look for similar items by category:


Table of Contents

Biology: UpdateDo we need biology studies for patient management?Gerneral Issues in the Management of MPNs:Critical Issues about the Diagnosis of MPNsPatient's Information and Examinations Needed before Planning Therapy Specific Issues of Treatment in PV and ET:Risk classificationGoal of TherapyFirst-line Therapy and Monitoring the Response in the Individual PatientPrimary and Secondary Antithrombotic ProphylaxisWhen to change Therapy: Second Line OptionsThe Evolution in Myelofibrosis and LeukemiaTreatment of PMF:Current Clinical NeedsRisk StratificationGoal of Therapy: Palliation and CurativeResearch Issues and Perspectives:New drugsOngoing Clinical TrialsHow to Design Clinical Studies in Rare Diseases